American Shared Hospital Services (NYSEAMERICAN:AMS) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS) in a research report released on Monday. The firm issued a hold rating on the stock.

American Shared Hospital Services Stock Performance

AMS opened at $3.27 on Monday. American Shared Hospital Services has a 52-week low of $2.16 and a 52-week high of $3.69. The stock has a market cap of $20.68 million, a price-to-earnings ratio of 40.85 and a beta of 0.70. The company has a current ratio of 1.98, a quick ratio of 1.98 and a debt-to-equity ratio of 0.49.

American Shared Hospital Services (NYSEAMERICAN:AMS) last posted its quarterly earnings data on Tuesday, May 14th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). American Shared Hospital Services had a return on equity of 4.29% and a net margin of 2.50%. The business had revenue of $5.22 million during the quarter, compared to analysts’ expectations of $5.01 million. On average, sell-side analysts predict that American Shared Hospital Services will post 0.29 earnings per share for the current fiscal year.

Institutional Trading of American Shared Hospital Services

A hedge fund recently bought a new stake in American Shared Hospital Services stock. Empowered Funds LLC acquired a new stake in American Shared Hospital Services (NYSEAMERICAN:AMS) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 10,468 shares of the company’s stock, valued at approximately $31,000. Empowered Funds LLC owned about 0.17% of American Shared Hospital Services at the end of the most recent reporting period. 23.16% of the stock is owned by institutional investors and hedge funds.

About American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.